ESR1
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
ESR1
Jun 20, 2024, 11:37 |
Insight
Filippo Montemurro: Intriguing preclinical findings of synergy between fulvestrant and capecitabile in ESR1 tumors
Filippo Montemurro, Senior Medical Director at Roche, shared on X: Pure estrogen receptor antagonists potentiate…
Jun 10, 2024, 07:18 |
Blog
Francisco J. Esteva: Emerging technologies are set to revolutionize the detection and application of biomarkers in cancer treatment
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Mar 14, 2024, 19:28 |
Drugs
François-Clément Bidard: A prospective study to document the efficacy of the combo Fulvestrant+Everolimus
Erika Hamilton, Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute, shared…
Dec 14, 2023, 16:23 |
Insight
SABCS23 Day 1 Highlights by Oncology Brothers
Oncology Brothers have recently shared their highlights from SABCS23. Below we feature the first day's…
All:
4
Posts:
1 - 100
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube